ReviewBiologics : targets & therapy2025

Brodalumab for Moderate-to-Severe Psoriasis: A Comprehensive Review of Efficacy, Safety, and Clinical Positioning.

Nickoulet Babaei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.